Report

Gender and Malaria Evidence Review

Gender-transformative approaches are needed to accelerate malaria prevention.

Date Published
12 Feb 2020
Authors
Elizabeth Katz (Senior Gender Integration Specialist at the Global Center for Gender Equality at Stanford University) Angela Hartley (Gender Integration Specialist at Stanford University)

INTRODUCTION

This comprehensive report reviews the existing evidence on:

  • How gender influences the adoption of malaria preventive interventions, healthcare-seeking behaviour, and access to treatment;
  • The current gaps and opportunities regarding the integration of gender into malaria research and development; and
  • Current gaps and opportunities in malaria advocacy and policy action at the global, regional, and national levels.

Overall, it calls for gender-intentional and transformative approaches to accelerate the success of malaria prevention, treatment, and elimination efforts. For example, malaria clinical trial designs could be made more effective and equitable by understanding and addressing the gender-specific barriers that limit the recruitment and retention of women.

KEY TAKEAWAYS

  1. Integrating malaria programs with maternal and child health systems can strengthen prevention efforts

    Evidence-based interventions include a) training, providing supplies to, and leveraging the reach of antenatal care providers and community health workers, b) and implementing women’s empowerment programs to reduce known barriers to accessing health care services.

  2. Gender-inclusive communications strategies can improve outcomes

    Gender-inclusive communications strategies that accompany universal coverage policies, such as targeted messages to men and boys who have greater occupational risk of exposure and transmission, can improve malaria prevention and treatment.

  3. Implement community-based case management

    Community-based case management that reduces costs and education programs that include key decision-makers – such as male family members – can ease the burden on women who must seek permission and resources for treatment, improve intra-household negotiation, and alleviate drug safety concerns (particularly for pregnant women).

  4. Measure the impacts to improve the evidence base

    The impact of women’s economic empowerment, community-based case management, and the gender composition of health worker teams on malaria intervention outcomes should be measured to strengthen the evidence base. Further, direct observation and sex-disaggregation of data can improve future surveillance programs.

  5. Integrate analysis into research agendas

    Sex and gender analysis should be purposefully and comprehensively integrated into the international malaria research agenda. Additionally, malaria clinical trial designs should be made more effective and equitable by understanding and addressing the gender-specific barriers that limit the recruitment and retention of women.

  6. Identify gender-related barriers

    Additional research is needed to identify the gender-related barriers to career development that contribute to the underrepresentation of women scientists, and databases on gender representation in research teams should be used to measure and track progress. Opportunities should be expanded for women’s equitable participation and career advancement. Furthermore, there are significant R&D gaps with regard to safe and effective malaria chemo-prevention and treatment for HIV-infected women, particularly pregnant women, and the barriers, such as stigma, that may limit their access to services.

  7. Develop policy guidance based on gender analysis

    Global technical guidance on gender integration into national malaria planning, policy, and programming can be strengthened in part by developing policy guidance based on gender analysis and accompanying toolkits to guide uptake of recommendations within a country’s specific social and political context. Additionally, the agendas and outputs of key global policy bodies, such as WHO, should commit to and facilitate strengthening the gender and malaria evidence base and adoption of best practices.

  8. Target advocacy and communication efforts

    Targeted advocacy and communication efforts – including through existing advocacy networks, global events, high-level stakeholder meetings, and scientific conferences – can raise the profile of gender dimensions of malaria, make the investment case for gender integration into elimination approaches, and strengthen political will to mainstream gender considerations in malaria policies and programs.

Biomedical research that integrates a gender lens can provide critical information on how risk is differentially distributed, how gender-specific pathways shape transmission, how access to care and treatment is limited by gender-based constraints, how the disease presents and impacts biologically, and how treatment and its effects on the body are differentially experienced.

Download the Report.

Suggested citation: Elizabeth Katz (Senior Gender Integration Specialist at the Global Center for Gender Equality at Stanford University), Angela Hartley (Gender Integration Specialist at Stanford University). Gender and Malaria Evidence Review : UNU-IIGH, 2026.

Related content

Policy Brief

Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment

Gender-related barriers and inequities in communities and health systems negatively affect access to health services, including vaccination.

15 May 2026

Policy Brief

Delivering Healthy Lives and Well-Being for Women and Girls: Noncommunicable Diseases and Universal Health Coverage

Policy brief on adopting a gendered lens in the management of NDCs to advance solutions to address gender disparities for effective UHC.

15 May 2026

News

Scientific Partnerships for Better Stenting

Julieta Merlo is at the core of an Argentinian-Uruguayan partnership to improve diseases related to age

12 Feb 2026

News

Bacterial Viruses Against Human Pathogens

Fellow Victoria Rodriguez is adding to our understanding of prospective industrial applications of phages

10 Feb 2026